REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE

The Receptor Binding Domain (RBD) of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) can recognize the human cell receptor, Angiotensin Converting Enzyme 2 (ACE2). This interaction is the initial step of virus infection in humans. Therefore, RBD is a protein target for therapy, vaccina...

Full description

Saved in:
Bibliographic Details
Main Author: Lalita Izdihar, Hana
Format: Final Project
Language:Indonesia
Subjects:
Online Access:https://digilib.itb.ac.id/gdl/view/72773
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:72773
spelling id-itb.:727732023-05-26T15:37:13ZREFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE Lalita Izdihar, Hana Kimia Indonesia Final Project SARS-CoV-2, RBD, refolding, fast dilution, spectrofluorometry. INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/72773 The Receptor Binding Domain (RBD) of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) can recognize the human cell receptor, Angiotensin Converting Enzyme 2 (ACE2). This interaction is the initial step of virus infection in humans. Therefore, RBD is a protein target for therapy, vaccination, and studying the pathogenicity of SARS-CoV-2. Escherichia coli expression system is an ideal host to produce recombinant proteins because of its fast growth rate and ability to produce a large amount of protein. However, RBD production in E. coli results in inclusion bodies that affects the function and structure of RBD protein. Inclusion bodies are a consequence of protein misfolding and generally result in the loss of activity. The aim of this study is to refold the recombinant SARS-CoV-2 RBD protein structure using rapid dilution and characterize the RBD structure using spectrofluorometry. The first stage of the study was to transform E. coli BL21 (DE3) cells with a recombinant plasmid containing the RBD gene. The obtained transformants were induced with isopropyl ?-D-1-thiogalactopyranoside (IPTG) to induce RBD protein expression. The RBD protein in inclusion bodies was dissolved in a buffer solution containing 8 M urea and purified by Ni-NTA affinity chromatography. The pure protein was then refolded using rapid dilution and characterized by spectrofluorometry. The transformed recombinant E. coli cells were able to grow in Luria Bertani (LB) medium containing ampicillin, and produced a band of 25 kDa on sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). This indicates that the cell transformation and RBD production stages were successfully conducted. The expressed protein was in the form of aggregates but was soluble in 8 M urea and produced a protein band of 50 kDa on SDS-PAGE. This result indicates the dimeric form of RBD in the denatured state. The 50 kDa protein band was more clearly visible after purification. The fluorescence spectrum after refolding showed a decrease in the percentage of fluorescence emission with decreasing urea concentration in the RBD solution. The normalized spectrum showed a maximum emission wavelength shift from red shift to blue shift. This wavelength shift is indicative of RBD conformational change from denatured to refolded state. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
topic Kimia
spellingShingle Kimia
Lalita Izdihar, Hana
REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
description The Receptor Binding Domain (RBD) of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) can recognize the human cell receptor, Angiotensin Converting Enzyme 2 (ACE2). This interaction is the initial step of virus infection in humans. Therefore, RBD is a protein target for therapy, vaccination, and studying the pathogenicity of SARS-CoV-2. Escherichia coli expression system is an ideal host to produce recombinant proteins because of its fast growth rate and ability to produce a large amount of protein. However, RBD production in E. coli results in inclusion bodies that affects the function and structure of RBD protein. Inclusion bodies are a consequence of protein misfolding and generally result in the loss of activity. The aim of this study is to refold the recombinant SARS-CoV-2 RBD protein structure using rapid dilution and characterize the RBD structure using spectrofluorometry. The first stage of the study was to transform E. coli BL21 (DE3) cells with a recombinant plasmid containing the RBD gene. The obtained transformants were induced with isopropyl ?-D-1-thiogalactopyranoside (IPTG) to induce RBD protein expression. The RBD protein in inclusion bodies was dissolved in a buffer solution containing 8 M urea and purified by Ni-NTA affinity chromatography. The pure protein was then refolded using rapid dilution and characterized by spectrofluorometry. The transformed recombinant E. coli cells were able to grow in Luria Bertani (LB) medium containing ampicillin, and produced a band of 25 kDa on sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). This indicates that the cell transformation and RBD production stages were successfully conducted. The expressed protein was in the form of aggregates but was soluble in 8 M urea and produced a protein band of 50 kDa on SDS-PAGE. This result indicates the dimeric form of RBD in the denatured state. The 50 kDa protein band was more clearly visible after purification. The fluorescence spectrum after refolding showed a decrease in the percentage of fluorescence emission with decreasing urea concentration in the RBD solution. The normalized spectrum showed a maximum emission wavelength shift from red shift to blue shift. This wavelength shift is indicative of RBD conformational change from denatured to refolded state.
format Final Project
author Lalita Izdihar, Hana
author_facet Lalita Izdihar, Hana
author_sort Lalita Izdihar, Hana
title REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
title_short REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
title_full REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
title_fullStr REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
title_full_unstemmed REFOLDING OF RECOMBINANT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) RECEPTOR BINDING DOMAIN (RBD) PROTEIN USING FAST DILUTION TECHNIQUE
title_sort refolding of recombinant severe acute respiratory syndrome coronavirus 2 (sars-cov-2) receptor binding domain (rbd) protein using fast dilution technique
url https://digilib.itb.ac.id/gdl/view/72773
_version_ 1822992704579043328